<DOC>
	<DOCNO>NCT02241616</DOCNO>
	<brief_summary>Liver Cirrhosis common pathological consequence chronic liver disease . Hepatitis B Virus ( HBV ) one etiologies Liver cirrhosis China . The effective inhibition HBV partially regress reverse liver fibrosis patient chronic Hepatitis liver cirrhosis due HBV , however patient keep existence development although HBV DNA under-detectable anti-virals . Theses refractory liver fibrosis require anti-fibrotic treatment focus regulation hepatic extracellular matrix , especially necessary patient advance fibrosis stage ie . liver cirrhosis . Fuzheng Huayu find enhance degradation collagens fibrotic liver good action liver fibrosis patient chronic hepatitis B . However , high quality clinical evidence demonstrate combination anti-viral anti-fibrotic therapy improve reversion refractory liver fibrosis liver cirrhosis due HBV . The primary objective study establish safety efficacy combination Entecavir Traditional Chinese Medicine refractory liver fibrosis liver cirrhosis due HBV .</brief_summary>
	<brief_title>Traditional Chinese Medicine Combined With Entecavir Treat Refractory Liver Fibrosis Liver Cirrhosis Due HBV</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Hepatitis B history 6 month history positive HBsAg Within 2 year Entecavir treatment , HBVDNA negative reach clinical endpoint ( HBeAg seroconversion HBsAg loss HBeAgpositive patient ; HBsAg loss antiHBs seroconversion HBeAgnegative patient ) Age 1860 Ishak fibrosis score biopsy within 6 month â‰¥5 , antifibrosis drug take within 6 month . ChildPugh &lt; 7 ( Stage A ) The patient patient 's guardian agree participate random control trial sign Informed Consent Form . Decompensated liver cirrhosis Liver cancer Liver histology conform chronic liver disease cause ( exclude fatty liver ) NonHBV Avihepadnavirus infect acute chronic hepatitis , autoimmune hepatitis , primary biliary cirrhosis , primary sclerosing cholangitis , inherit metabolic liver disease , drug toxic hepatitis , Alcoholic liver disease . Have psychiatric history uncontrollable epilepsy patient . Uncontrollable diabetic patient History hemoglobin disease ( Alpha globin generation barrier anemia , Sickle cell deficiency , Spherocytosis ) Hemolytic anemia patient cause reason like autoimmunity . Severe background disease like chronic respiratory failure , circulatory failure , kidney failure etc . In situ organ transplantation ( liver , kidney , lung heart ) bone marrow transplantation stem cell transplantation . Immunocompromised patient : HIV infection take immunosuppressor Glucocorticoid ( cyclosporin , azathioprine , adrenocortical hormone ) within 3 month chemotherapy drug ( cyclophosphamide , ammonia cancer chemotherapy ) radioactive therapy . Gestation lactation period woman woman plan get pregnant study period . Patient allergy experimental drug . Using history antiviral drug within 6 month . Patients participate trial . Other situation PI think patient exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>